Global Paclitaxel Revenue Is Nearly 80 M USD In 2017

New report published by Global Info Research which offers insights on the global Paclitaxel-eluting Stent market.

Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".

Click to view the full report TOC, figure and tables:
https://www.globalinforesearch.com/global-paclitaxel-eluting-stent-market_p66467.html

Global Paclitaxel-eluting Stent Market: Forecast by Type / Application / Region

Paclitaxel is a white crystalline powder, odorless and tasteless. It is insoluble in water and soluble in chloroform, acetone and other organic solvents.

The major players in global Paclitaxel market include: Phyton, ScinoPharm, Novasep, Samyang, Polymed, TAPI (Teva), Fresenius-kabi, Huiang biopharma, Southpharma, Yunnan Hande, Hainan Yew Pharm, Jiangsu Yew Biotechnology.

On the basis on the type, this report covers: Natural Paclitaxel API, Semi-synthetic Paclitaxel API.

On the basis on the end users/applications, this report covers: Ovarian Cancer, Cervical Cancer, Breast Cancer, Other.

In the last several years, global market of Paclitaxel developed rapidly, with an average growth rate of 12.3%. In 2017, global revenue of Paclitaxel is nearly 80 M USD; the actual production is about 2600 Kg.

The classification of Paclitaxel includes Natural Paclitaxel API and Sem-synthetic Paclitaxel API, and the proportion of Natural Paclitaxel API in 2017 is about 31.3%, and the proportion is decreasing trend from 2012 to 2017.

Paclitaxel is widely sales for Ovarian Cancer, Cervical Cancer, Breast?Cancer and Others. The most proportion of Paclitaxel is sales in Ovarian?Cancer, and the consumption proportion is about 46% in 2017.

North America is the largest consumption place, with a consumption market share nearly 52.3% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 19.6%, China is also an important sales region for the Paclitaxel.

Market competition is intense. Phyton, ScinoPharm, Novasep, Samyang, etc. are the leaders of the industry. They hold the key technologies and patents, with high-end customers. They have formed global market channel of the industry. However, with the future expanding market, there will be more manufacturers in the future.

Ask for Discount on Research Report and Request Sample Copy of Report@
https://www.globalinforesearch.com/global-paclitaxel-eluting-stent-market_p66467.html

Related Information:
United States Paclitaxel-eluting Stent Market 2018 Forecast to 2023
Europe Paclitaxel-eluting Stent Market 2018 Forecast to 2023
North America Paclitaxel-eluting Stent Market 2018 Forecast to 2023
Asia-Pacific Paclitaxel-eluting Stent Market 2018 Forecast to 2023
China Paclitaxel-eluting Stent Market 2018 Forecast to 2023
EMEA Paclitaxel-eluting Stent Market 2018 Forecast to 2023
Global Paclitaxel-eluting Stent Market 2018 Forecast to 2023

About Us:
GlobalInfoResearch is a report publisher, a customer, interest-based suppliers. Is in the best interests of our clients, they determine our every move. At the same time, we have great respect for the views of customers. With the improvement of the quality of our research, we develop custom interdisciplinary and comprehensive solution. For further development, we will do better and better. GlobalInfoResearch will with excellent professional knowledge and experience to carry out all aspects of our business. At the same time, we will thoroughly look for information, to give a more comprehensive development.

Contact US :
JOE
Sales Director (Global Info Research)
E-mail: report@globalinforesearch.com
Tel: +86-15521064060 00852-58197708(HK)
Add: RM 1605C HO KING COMM CTR 2-16 FA YUEN ST MONGKOK KL Hong Kong
Website: http://www.globalinforesearch.com

This release was published on openPR.